Co-designing a pharmacist-led emergency department transition-of-care blueprint
This participatory study offers geriatric pharmacists a theory-informed, stakeholder-vetted template for building medication-safety interventions at the high-risk emergency department to home transition, but stops short of testing clinical outcomes.
pharmacist-led transition of careemergency departmentmedication reconciliationgeriatric pharmacypolypharmacyco-designparticipatory health researchqualitative studyimplementation scienceQatarmedication therapy managementGeriatrics / Geriatric Pharmacy
Background Information
Pharmacist-led transitions can reduce medication harm post-ED discharge.
Transitions from the emergency department (ED) to home are high-risk periods for medication-related harm, especially in older adults. A pharmacist-led transition-of-care program was co-designed, emphasizing discharge medication reconciliation, prescription review, and patient follow-up, deemed highly feasible with an 83% mean rating. The study outlines a feasible intervention for improving medication safety during transitions, but further testing in a pilot randomized controlled trial is needed. Co-designed pharmacist-led interventions may enhance medication safety during ED transitions for older adults.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Authors:Alhmoud E, Barazi R, Thomas B, Zakaria A, Andraous L, El Enany R, Abdulrouf PV, Pathan S, Nazar H, Ibrahim MIM, Hadi MA
Citation:Alhmoud E, Barazi R, Thomas B, et al. Codesigning a pharmacist-led transition of care program in the emergency department: a qualitative participatory study. International journal of clinical pharmacy. 2026. doi:10.1007/s11096-026-02210-3
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?
Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.